Canuretic 16/12,5 mg, Tablets
PDF Leaflet Revision Date: 02 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for essential hypertension in patients stabilized on individual components.
Dosage (summary)
Take once daily, with or without food.
Onset of Action / Duration
Onset: 2 hours, Duration: 4 weeks for full effect.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established; discontinue if pregnancy occurs; avoid during breastfeeding.
Key Drug Interactions
- Lithium
- Warfarin
- Potassium-sparing diuretics
Contraindications
- Hypersensitivity to components
- Moderate to severe hepatic impairment
- Gout
- Angioedema history
- Moderate to severe renal impairment
Common side effects
- Hyperglycaemia
- Hypokalaemia
- Light-headedness
- Weakness
Counselling Points
- Monitor for skin lesions
- Stay hydrated
- Report dizziness or hypotension
Serious warnings
- Risk of hypotension with dual RAAS blockade
- Potential for non-melanoma skin cancer
- Monitor renal function in severe impairment
Important Disclaimer
The Canuretic 16/12,5 mg, Tablets professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
